Member Log-in

I forgot my password

Not a Member? Register

CHAI Shares High Level Review of Findings from New Procurement Assessment Framework

CHAI recently developed a review framework to help EPI programs better understand the disruptions and challenges pertaining to procurement that might result from Gavi transition and identify a way forward without compromising vaccine coverage. In close collaboration with EPI teams and partners, CHAI assessed current procurement processes and identified challenges along the following 4 dimensions – governance and regulations, planning, execution, and evaluation. We are pleased to share a high-level review of these findings. Looking ahead, CHAI is in the process of finalizing these assessments and they have begun co-developing with government multi-year mitigation plans. CHAI also intends to bring in-country lessons and test cases to the global level to inform policy and future investments. Please do not hesitate to reach out to CHAI for any questions or clarifications. 

You May Also Like

New Rotavirus Vaccine Prequalified by WHO

Bharat Biotech announced that ROTAVAC® has achieved pre-qualification by the World Health Organization (WHO), making it available for procurement by United Nations agencies and GAVI, the Vaccine Alliance, for use in low-resource countries. ROTAVAC is substantially cheaper than current rotavirus vaccines on the global market and will be available at $1/dose. Read more about ROTAVAC’s … Continued

New Guide Helps Countries Assess Immunization Financing Options

Helen Saxenian, Cheryl Cashin, and Paul Wilson, Results for Development Maintaining high rates of immunization coverage, which is essential for a persistent reduction in the incidence of vaccine-preventable infectious diseases, requires a sufficient and sustained investment. In order to ensure that governments are making adequate investments in immunization financing and are doing so through sustainable … Continued

Choose a Language